ED Cervical Cancer Screening Intervention Detects Abnormal Findings at Three Times the National Rate
Emergency department-based cervical cancer interventions identify precancerous lesions and high-risk human papillomavirus at rates higher than the national average, a study shows.
The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...
A recent study shows that menstrual blood can be a new basis to test cervical cancer. It is considered to be better and more ...
Testing menstrual blood for human papillomavirus (HPV) could be a "robust alternative or replacement" for current cervical ...
Looking for signs of the cancer in a more convenient way could help women access the test and prevent the disease occurring, ...
It is recommended that women between 30 and 65 undergo co-testing with Human papillomavirus (HPV) and Pap smear testing every five years or Pap testing alone every three years.
Our editors independently select these products. Making a purchase through our links may earn Well+Good a commission Like most women, I don’t exactly look forward to gyno appointments. It’s nothing ...
The Future of Cervical Cancer Screening Researchers and public health experts view menstrual blood testing as a potential new ...
Dr Jayaraman emphasises the importance of recognising early symptoms of cervical cancer, urging women to seek medical advice and prioritize regular screenings.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results